AbbVie, Inc.
(NYSE : ABBV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.66%134.030.7%$2124.95m
PFEPfizer Inc. 2.31%33.630.9%$1411.52m
MRKMerck & Co., Inc. -0.70%76.330.7%$1270.98m
ABBVAbbVie, Inc. -2.38%73.342.3%$1177.90m
BMYBristol-Myers Squibb Co. 0.63%55.561.0%$1081.19m
LLYEli Lilly & Co. -1.89%139.501.1%$890.49m
NVSNovartis AG 0.04%83.630.2%$307.27m
AZNAstraZeneca Plc 0.46%43.961.2%$292.54m
GSKGlaxoSmithKline Plc -1.54%37.120.2%$251.81m
FTSVForty Seven, Inc. 0.03%95.460.0%$173.71m
NVONovo Nordisk A/S 0.86%59.820.1%$170.40m
SNYSanofi 3.03%44.830.2%$169.69m
BHCBausch Health Cos., Inc. -2.14%13.290.0%$88.41m
RARXRa Pharmaceuticals, Inc. -0.03%48.000.8%$84.78m
RGENRepligen Corp. 1.30%98.217.1%$74.31m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.